Drugs / Ginkgolides Meglumine Injection
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02046031 | Feb → Jun 2014 | ischemic stroke | Jiangsu Kanion Pharmaceutical Co., Ltd | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ginkgolides Meglumine Injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02046031 ↗ |
| Route | Intravenous | “Intravenous drip slowly.” NCT02046031 ↗ |